Skip to main content
. Author manuscript; available in PMC: 2012 Sep 16.
Published in final edited form as: Cancer Res. 2008 Feb 15;68(4):1144–1153. doi: 10.1158/0008-5472.CAN-07-1756

Figure 6.

Figure 6

Immunodetection of mTOR/HIF-1α downstream targets in control and mTOR-RR expressing HNSCC xenografts following rapamycin treatment. Immunohistochemistry was performed on tissue sections using antibodies against pS6, HIF-1α, Glut-1 and VEGF to determine the effects of rapamycin. pS6 and VEGF protein were mainly localized in cytoplasm. HIF-1α was localized in nuclei of tumor cells. Glut-1 is visible at the cell membrane and cytoplasm.